Fundraising Fox
/Companies
Sign in

Krystal Biotech

Pittsburgh, US · Founded 2017 · 4 known investors

Find your way into Krystal Biotech

Sign up to find every way you can get introduced to Krystal Biotech

  • Your email: who you already know at Krystal Biotech, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Krystal Biotech team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.

BiotechHealthtechMedical Devices

Founders & leadership

Krystal Biotech was founded in 2017 by Suma Krishnan and Krish Krishnan.

SKSuma Krishnan
Suma KrishnanPresident, Research & DevelopmentPresident, Research & Development at Krystalbio
KKKrish Krishnan
Krish KrishnanChairman & CEOChairman & CEO at Krystalbio
DN
Doug NorbyNamed on SEC filing
DR
Dino RossiNamed on SEC filing

Board

DJ
Dan JanneyBoard directorManaging Director at Alta Partners

Investors · 4

Frazier Life Scienceslisted by Frazier Life SciencesPalo Alto

How we know: Frazier Life Sciences's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

Alta PartnersinferredJackson · $1M – $12Mvia Dan Janney · board

How we know: board seat on SEC Form D · Not right? Tell us

Avoro VenturesreportedNew York

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$11.3M disclosed across 1 round · 2017

▶$11.3MraisedAug 2017 · 16 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Doug NorbyDirector
  • Dan JanneyDirector
  • Dino RossiDirector
  • Suma M. KrishnanDirector
  • Krish S. KrishnanExecutive Officer, Director
Offering amount
$11.3M
Amount sold
$11.3M
First sale
Aug 2017
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

InvenInven provides AI-powered workflows for investment and consulting firms to automatically generate company materials such as market maps, financial profiles, and competitive landscapes from structured data. The platform serves management consulting firms and investment professionals who need to produce analyst-ready documents and decks at scale.
Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.

Companies working in the same space as Krystal Biotech.

Frequently asked questions

What does Krystal Biotech do?
Krystal Biotech discovers, develops, and commercializes genetic medicines, including gene therapy programs for rare diseases such as dermatological conditions. The company operates across the US, Europe, and Japan.
Who founded Krystal Biotech?
Krystal Biotech was founded by Suma Krishnan, Krish Krishnan in 2017.
Who are Krystal Biotech's investors?
Krystal Biotech's investors include Avoro Capital Advisors, Frazier Life Sciences, Alta Partners, Avoro Ventures.
How much funding has Krystal Biotech raised?
Krystal Biotech has disclosed $11.3M raised across 1 round.
Where is Krystal Biotech headquartered?
Krystal Biotech is headquartered in Pittsburgh, US.